NLRP3 and cirrhosis of liver: Quantitative analysis showed that NLRP3-positive cells in the high dose Exo-rBMMSC group were significantly reduced compared to those in the liver cirrhosis group (Figure 5H, *** p < 0.001), but were not significantly different compared to those in the low and medium dose Exo-rBMMSC groups (Figure 5H, p > 0.05).